Facebook
Twitter
Telegram
Report an ErrorQualigen Therapeutics Financial Ratios 2011-2024 | QLGN
Annual Financial Ratios Qualigen Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.1 | -56.8 | -4.4 | -0.2 | -0.9 | -1.6 | -0.5 | - | - | - | - |
P/S |
0.8 | 0.3 | 18.3 | - | - | - | - | - | - | - | - | - |
EPS |
-4.8 | -6.1 | -1.2 | -1.1 | -3.7 | -5.0 | -2.0 | -3.1 | -6.8 | - | - | - |
EV (Enterprise Value) |
7.12 M | -9.33 M | 83.2 M | 44.4 M | 1.36 M | -12.7 M | 25.9 M | -10.4 M | -2.75 M | - | - | - |
EBITDA per Share |
-5.74 | -7.69 | -0.103 | -1.24 | -80.1 | -89.1 | -513 | -755 | - | - | - | - |
EV/EBITDA |
0.5 | -79.1 | -3.9 | 0.3 | 2.0 | -1.2 | 1.3 | - | - | - | - | |
PEG |
-0.0 | -0.0 | -0.57 | -0.07 | -0.02 | -0.01 | -0.05 | 0.0 | - | - | - | - |
P/B |
0.4 | 0.1 | -52.7 | 40.4 | 0.3 | 0.4 | 7.3 | 0.3 | - | - | - | - |
P/CF |
-0.3 | -0.1 | -740.6 | -3.1 | -0.2 | -1.0 | -2.0 | -0.7 | - | - | - | - |
ROE % |
-257.62 | -108.04 | 92.72 | -921.20 | -179.71 | -39.07 | -448.07 | -59.84 | - | - | - | - |
ROA % |
-97.68 | -78.37 | -48.05 | -362.28 | -110.11 | -34.44 | -254.04 | -54.79 | - | - | - | - |
ROCE % |
-306.55 | -136.81 | 92.83 | -985.86 | -181.07 | -39.26 | -449.58 | -60.66 | - | - | - | - |
Current Ratio |
1.8 | 3.6 | 0.3 | 1.3 | 2.6 | 8.4 | 2.3 | 11.8 | - | - | - | - |
DSO |
49.8 | 34.1 | 46.4 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | 60.6 | - | - | - | - | - | - | - | - | - |
DPO |
- | - | 80.7 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
49.8 | 34.1 | 107.0 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
49.8 | 34.1 | 26.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Qualigen Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.64 | -0.69 | -0.78 | - | -0.8 | -1.12 | -1.22 | - | -0.1 | -0.19 | -0.19 | - | -0.41 | -0.41 | -2.12 | - | -0.06 | -0.11 | -0.58 | - | -0.86 | -0.71 | -0.41 | - | -0.14 | -1.41 | -1.44 | - | -0.41 | -0.48 | -0.36 | - | -0.4 | -4.18 | -3.37 | - | -0.92 | -1.18 | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.7 | -0.73 | - | -0.85 | -1.12 | -1.41 | - | -0.16 | -0.25 | -0.21 | - | -0.18 | -0.18 | -0.29 | - | -0.05 | -0.08 | -0.59 | - | -0.87 | -0.71 | -0.41 | - | -0.14 | -1.41 | -1.45 | - | -0.41 | -0.48 | -0.37 | - | -0.4 | -3.8 | -3 | - | -0.56 | -0.84 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-36.80 | -287.52 | -139.53 | -79.77 | -108.24 | -111.23 | -132.93 | -104.80 | -149.15 | -165.02 | -165.34 | -190.25 | -157.83 | -81.07 | 43.33 | -315.33 | -364.83 | -446.75 | -565.00 | -109.13 | -119.12 | -79.62 | -51.18 | -28.06 | -114.00 | -189.94 | -281.08 | -263.07 | -284.05 | -219.08 | -132.48 | -44.71 | -42.87 | -20.05 | -3.07 | 4.54 | 4.54 | 2.70 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-155.43 | -87.49 | -76.79 | -56.41 | -74.92 | -75.77 | -87.26 | -66.03 | -93.88 | -103.22 | -103.94 | -119.50 | -131.78 | -116.21 | -100.21 | -76.66 | -106.98 | -125.03 | -136.57 | -66.86 | -75.67 | -54.15 | -39.35 | -24.73 | -73.46 | -113.37 | -161.97 | -149.15 | -168.36 | -138.84 | -94.71 | -40.93 | -49.92 | -39.71 | -39.82 | -22.19 | -22.19 | -13.20 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-86.59 | -277.74 | -125.58 | -81.28 | -126.35 | -149.62 | -187.51 | -141.19 | -161.51 | -136.76 | -96.77 | -54.68 | -28.33 | 18.34 | 109.40 | -337.19 | -386.87 | -462.91 | -572.08 | -109.82 | -119.84 | -80.16 | -51.53 | -28.15 | -114.41 | -190.66 | -282.17 | -264.33 | -285.50 | -220.41 | -133.41 | -44.98 | -43.22 | -20.30 | -3.34 | 4.42 | 4.42 | 2.66 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.7 | 1.3 | 1.6 | 1.9 | 3.3 | 3.3 | 3.6 | 3.6 | 3.0 | 2.6 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | - | 1.0 | 1.7 | 2.2 | 2.6 | - | 2.6 | 2.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | 30.6 | 27.0 | - | 41.9 | 41.9 | 89.5 | - | 55.3 | 66.5 | 35.5 | - | 67.1 | 67.1 | 31.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | 1399.7 | 1717.9 | 2873.9 | - | 3542.0 | 3192.4 | 2797.3 | - | 2718.8 | 3346.3 | 122.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 759.3 | 1214.0 | 2203.6 | - | 2663.8 | 2069.5 | 1500.0 | - | 1428.0 | 1757.5 | 246.2 | - | - | 657.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 30.6 | 27.0 | - | 1441.6 | 1759.8 | 2963.4 | - | 3597.3 | 3258.9 | 2832.8 | - | 2785.9 | 3413.3 | 153.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 30.6 | 27.0 | - | 682.3 | 545.8 | 759.8 | - | 933.5 | 1189.5 | 1332.8 | - | 1358.0 | 1655.8 | -92.8 | - | - | -657.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency